By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The second day of the UBS Global Life Sciences Conference in New York featured several life science tools and molecular diagnostics companies making their pitches to the investor community.

Below are capsules from their presentations and breakout sessions.

Cepheid

Cepheid CFO Andrew Miller provided investors with an update on the firm's ambitious plans for rolling out new molecular tests over the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.